RT Journal Article
SR Electronic
T1 Response to: ‘Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial’’ by Wang <em>et al</em>
JF Annals of the Rheumatic Diseases
JO Ann Rheum Dis
FD BMJ Publishing Group Ltd and European League Against Rheumatism
SP e68
OP e68
DO 10.1136/annrheumdis-2021-219882
VO 82
IS 3
A1 Renaud Felten
A1 Jacques-Eric Gottenberg
YR 2023
UL http://ard.bmj.com/content/82/3/e68.abstract
AB